Event Centre
Event Centre
The Event Centre is your hub for session recordings and expert highlights from our medical education events over the years, offering a comprehensive archive of learning and insights.
.png?width=1208&height=908&format=webp&quality=60 "Image container (2)")
Hear from the Experts - Discussions filmed at EAU 2026
Prof. Alison Birtle
Prof. Birtle highlights the need for holistic patient assessment and responsive treatment strategies in mHSPC based on consistent trial results, along with unanswered questions around PSA‑driven decisions.
Prof. Marc-Olivier Timsit
Prof. Timsit discusses how multidisciplinary collaboration, genetic testing, trial interpretation and treatment selection can shape modern management of metastatic prostate cancer.
Prof. Gunhild von Amsberg
Prof. von Amsberg highlights the importance of aligning mHSPC treatment choices with individual patient goals, quality of life, and clinical factors.
Prof. Dr. Sofie Verbeke
Prof. Verbeke outlines patient considerations and timing of BRCA testing, and how evolving molecular and digital pathology can improve personalised prostate cancer care.
EMUC 2025
Watch Prof. Dr. Christian Schwentner, Prof. Dr. Athanasios Papatsoris and Prof. Gert Attard examine how PSA response guides optimal care in mHSPC and share approaches to improve outcomes in HRR-mutant diease.
Driving optimal patient outcomes with personalised strategies in mHSPC - Full session video
Hear from the Experts - Discussions filmed at EMUC 2025
Prof. Dr. Christian Schwentner
Prof. Dr. Christian Schwentner discusses new research on mHSPC treatment, the role of biomarkers, and key barriers to better prostate cancer care.
Prof. Dr. Athanasios Papatsoris
Prof. Dr. Athanasios (Thanos) Papatsoris discusses the need for better patient stratification and evidence-based, optimised treatment for a range of patients with mHSPC.
Prof. Gert Attard
Prof. Gert Attard explores how early genetic testing and new therapies are transforming prostate cancer care.
ESMO 2025
Watch the expert panel including Dr. Elena Castro, Prof. Dr. Axel Heidenreich and Dr. Alejo Rodríguez-Vida discuss key considerations in GU care.
The Power of Precision Medicine: Transforming Patient Outcomes in GU Oncology - Full session video
Expert highlights
Optimising outcomes: Patient-centred care in mHSPC
Dr. Alejo Rodríguez-Vida explores optimising patient-centred care in mHSPC, including treatment personalisation and insights from recent clinical analyses.
Timely testing in prostate cancer: Addressing the unmet needs
Prof. Dr. Axel Heidenreich highlights the importance of early genomic testing to guide treatment decisions for patients with mHSPC and HRR mutations.
Hear from the Experts – Discussions filmed at ESMO 2025
Dr. Elena Castro
Dr. Elena Castro discusses how genetic testing, treatment personalisation, and biomarker-driven strategies can address unmet needs in mHSPC while balancing rapid clinical advances with practical implementation challenges.
Prof. Dr. Axel Heidenreich
Prof. Dr. Axel Heidenreich addresses the role of molecular testing, emerging trial data, and strategies to advance personalised, patient-centred care across the prostate cancer journey.
Dr. Alejo Rodríguez-Vida
Dr. Alejo Rodríguez-Vida examines how emerging data and research can guide personalised treatment, address unmet needs, and shape the future of care for patients with mHSPC.
UROonco 2025
Watch below as Dr. Miguel Ramírez-Backhaus, Prof. Jozefina Casuscelli and Prof. Gert Attard explore the importance of early detection and screening in metastatic prostate cancer.
(Bio) Markers and milestones at the crossroads in mHSPC care - Full session video
Hear from the Experts – Discussions filmed at UROonco 2025
Dr. Miguel Ramírez-Backhaus
Dr. Miguel Ramírez-Backhaus discusses the value of real-world data, decision-making around doublets versus triplets, and the importance of shared decision making for patient outcomes.
Prof. Jozefina Casuscelli
Prof. Jozefina Casuscelli outlines barriers to overcome for biomarker-driven care, the combination of PSA dynamics with other key factors for fully informed treatment decisions, and the value of collaboration between healthcare professionals and with patients.
Prof. Gert Attard
Prof. Gert Attard explores the clinical implications of the CAPTURE and AMPLITUDE studies, the role of shared decision making to balance survival advantage with toxicity, and choosing the right treatment for the right patient.
The recorded content may not be available in your country. To request access to recordings and session materials, please contact our team.
Contact us
To report an Adverse Event (medication side-effect) or a Product Quality Complaint (an issue with one of our products), please select the appropriate link from the Contact dropdown menu. To submit a medical information request, choose the Medical Information page.
Abbreviations
BRCA, breast cancer gene; GU, genitourinary; HRR, homolgous recombinant repair; mHSPC, metastatic hormone-sensitive prostate cancer; PSA, prostate-specific antigen.
CP-554489 - July 2026
